✦ LIBER ✦

New consecutive high-dose chemotherapy modality with fractionated blood stem cell support in the treatment of high-risk pediatric solid tumors: a feasibility study

✍ Scribed by Kajiume, T; Kawano, Y; Takaue, Y; Abe, T; Watanabe, T; Okamoto, Y; Makimoto, A; Suenaga, K; Suzuya, H; Sato, J

Book ID: 110010383
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 59 KB
Volume: 21
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with blood stem-c

High-dose chemotherapy with blood stem-cell transplantation in the treatment of solid tumors and hematological malignancies

✍ H. Goldschmidt; R. Haas 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 228 KB

Successive double high-dose chemotherapy

Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center

✍ Sung, K W; Yoo, K H; Chung, E H; Jung, H L; Koo, H H; Shin, H J; Lee, S K; Lim, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Randomized Study of Cefepime versus Ceft

Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia

✍ Antonio Jimeno; Alberto Arcediano; Susana Bezares; María Luz Amador; Lucía Gonzá 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 647 KB

The feasibility of neoadjuvant high-dose

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma : Results of a phase II study

✍ Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the ≥ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant high‐dose chemotherapy (HDC) regimen, respectively. ## METHODS Twenty‐two patients with AJCC Stage IIB high‐grade o

386 High-dose chemotherapy with stem cel

386 High-dose chemotherapy with stem cell support in high-risk primary breast cancer. An analysis of the effect on overall survival the Danish experience from a comparison study

✍ T. Palshof; S. Werner Hansen; C. rose; S. Møller; P. Hokland; I. Svane; F. Hanse 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB